Physician profile
Kylin T Kovac
NPI 1417261744
$1,715.90
in general payments reported to CMS, 2019-2025
16 companies · $869 in 2025
The $869 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.32 · 2020: $33.61 · 2021: $117 · 2022: $198 · 2023: $82.97 · 2024: $320 · 2025: $869.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,272.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $360.70 | 2021-2024 | Sonicanchor, Swanson, Ortholoc 2 Lapifuse |
| Smith+Nephew, INC. | $337.95 | 2024-2025 | Grafix Pl, Stravix, Grafix |
| Paragon 28, INC. | $309.00 | 2025 | Bun-Yo-Matic, Grappler |
| Curonix LLC | $172.28 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Integra Lifesciences Corporation | $126.58 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Active Medical, LLC | $94.27 | 2019-2023 | |
| Ani Pharmaceuticals, INC. | $56.04 | 2025 | Purified Cortrophin Gel |
| Medtronic, INC. | $50.51 | 2024-2025 | Intellis Adaptivestim, Inceptiv |
| Zimmer Biomet Holdings, INC. | $48.28 | 2019-2020 | |
| Organogenesis INC. | $46.51 | 2021 | |
| Kerecis Limited | $31.81 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Nalu Medical, INC. | $22.67 | 2025 | Nalu Neurostimulation System |
| Amgen INC. | $20.04 | 2025 | Krystexxa |
| Urgo Medical North America, LLC | $15.41 | 2024 | Urgok2 |
| Horizon Therapeutics Plc | $13.45 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $10.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kylin Kovac listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.